The reverse signaling enables transendothelial migration of cancer cells via dissolution of adherens junctions through p38-increased actin contractility and opening of IEJs and but also via physical defect of the endothelial barrier as a consequence of endothelial cell necroptosis. The gene discussed is MAPK1; the disease is cancer.